摘要
治疗耐药性仍然是成功治疗癌症的主要障碍。上皮-间质转化 [EMT] 是一种细胞重编程过程,涉及胚胎发生和器官发育,并受 ZEB1/2 等多种转录因子 [EMT-TF] 的调节,因其在肿瘤进展和转移中的作用而得到认可。最近,越来越多的证据表明 EMT 与癌症治疗耐药有关,但这一发现背后的实际机制仍然难以捉摸。例如,无论是 EMT 状态本身还是调节癌症化学或放射抗性的 EMT-TF,仍然存在争议。在这里,我们总结了 EMT 程序的分子机制和癌症中的化疗耐药性,并特别提到了 DNA 损伤反应 [DDR]。我们深入了解 EMT 程序和癌症中 DNA 修复机制之间存在的分子相互作用,以及这种相互作用如何影响治疗反应。我们回顾了通过 DNA 损伤修复轴将 EMT 和耐药性联系起来的相互矛盾的研究。我们绘制的科学证据证明了包括 EMT-TF 在内的几种分子信号如何协同工作以诱导 EMT 并赋予 EMT 易感细胞干性特性。我们强调了与 EMT 衍生的干细胞样状态相关的增强型 DNA 损伤修复系统在促进治疗抗性中的作用,并提出了一种对抗癌症治疗抗性的多靶向模式。
关键词: 癌症、EMT、治疗抗性、干性、DNA 损伤修复、分子相互作用。
Current Molecular Medicine
Title:Deeper Insight in Metastatic Cancer Progression; Epithelial-to- Mesenchymal Transition and Genomic Instability: Implications on Treatment Resistance
Volume: 21 Issue: 10
关键词: 癌症、EMT、治疗抗性、干性、DNA 损伤修复、分子相互作用。
摘要: Therapy resistance remains the major obstacle to successful cancer treatment. Epithelial-to- mesenchymal transition [EMT], a cellular reprogramming process involved in embryogenesis and organ development and regulated by a number of transcriptional factors [EMT-TFs] such as ZEB1/2, is recognized for its role in tumor progression and metastasis. Recently, a growing body of evidence has implicated EMT in cancer therapy resistance, but the actual mechanism that underlies this finding has remained elusive. For example, whether it is, the EMT states in itself or the EMT-TFs that modulate chemo or radio-resistance in cancer is still contentious. Here, we summarise the molecular mechanisms of the EMT program and chemotherapeutic resistance in cancer with specific reference to DNA damage response [DDR]. We provide an insight into the molecular interactions that exist between EMT program and DNA repair machinery in cancer and how this interaction influences therapeutic response. We review conflicting studies linking EMT and drug resistance via the DNA damage repair axis. We draw scientific evidence demonstrating how several molecular signalling, including EMT-TFs, work in operational harmony to induce EMT and confer stemness properties on the EMT-susceptible cells. We highlight the role of enhanced DNA damage repair system associated with EMT-derived stem cell-like states in promoting therapy resistance and suggest a multi-targeting modality in combating cancer treatment resistance.
Export Options
About this article
Cite this article as:
Deeper Insight in Metastatic Cancer Progression; Epithelial-to- Mesenchymal Transition and Genomic Instability: Implications on Treatment Resistance, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1566524021666210202114844
DOI https://dx.doi.org/10.2174/1566524021666210202114844 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers